PubRank

P Amouyel

Author PubWeight™ 227.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994 12.24
2 Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999 10.46
3 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013 9.46
4 Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005 5.60
5 The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007 3.81
6 Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003 3.55
7 Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet 2001 2.70
8 APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011 2.31
9 Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 2013 2.25
10 Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular disease). Circulation 1999 2.19
11 Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 2004 2.18
12 The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J 2001 2.08
13 Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993 2.06
14 The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998 2.04
15 Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999 1.95
16 High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 2012 1.84
17 Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 1998 1.74
18 Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet 1999 1.73
19 Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 2008 1.71
20 Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 2009 1.70
21 Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke 1994 1.65
22 Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology 2007 1.64
23 Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry 2011 1.59
24 The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J 2002 1.58
25 Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology 2011 1.57
26 D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 1997 1.55
27 Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord 2001 1.53
28 Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 1998 1.53
29 Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004 1.52
30 Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005 1.52
31 Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 1.51
32 APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005 1.50
33 Sex differences in awareness and control of hypertension in France. J Hypertens 1997 1.49
34 Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J 2000 1.45
35 A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992 1.45
36 Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med 2009 1.27
37 Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997 1.27
38 Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000 1.25
39 Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 2004 1.22
40 Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry 2012 1.20
41 Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998 1.20
42 Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet 2000 1.18
43 A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 1998 1.17
44 Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998 1.17
45 The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 2000 1.16
46 A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998 1.14
47 Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002 1.14
48 Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet 2001 1.14
49 Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994 1.12
50 Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999 1.09
51 Different alcohol drinking and blood pressure relationships in France and Northern Ireland: The PRIME Study. Hypertension 2001 1.08
52 Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet 1997 1.08
53 TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet 2004 1.07
54 The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997 1.07
55 Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet 1991 1.05
56 Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004 1.01
57 Psychosocial risk factors for heart disease in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Int J Epidemiol 2002 1.01
58 Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000 1.01
59 Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? J Neurol Neurosurg Psychiatry 2005 1.01
60 Resting heart rate, mortality and future coronary heart disease in the elderly: the 3C Study. Eur J Cardiovasc Prev Rehabil 2011 1.01
61 Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. J Neurol Neurosurg Psychiatry 2002 1.01
62 Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1994 1.01
63 Incidence, case fatality, risk factors of acute coronary heart disease and occupational categories in men aged 30-59 in France. Int J Epidemiol 1997 1.01
64 Association between nutrition knowledge and nutritional intake in middle-aged men from Northern France. Public Health Nutr 2001 0.99
65 The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab 2003 0.98
66 ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci Lett 1995 0.96
67 Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000 0.96
68 Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML. Leukemia 2007 0.96
69 APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet 1997 0.95
70 Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord 2007 0.95
71 Influence of parental history of hypertension on blood pressure. J Hum Hypertens 1999 0.95
72 Sedentary behaviour, physical activity and dietary patterns are independently associated with the metabolic syndrome. Diabetes Metab 2012 0.95
73 Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. J Hum Hypertens 2010 0.95
74 Induction of proliferation of neuroretina cells by long terminal repeat activation of the carboxy-terminal part of c-mil. Mol Cell Biol 1987 0.94
75 Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost 1998 0.94
76 No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett 1999 0.94
77 Impact of REV-ERB alpha gene polymorphisms on obesity phenotypes in adult and adolescent samples. Int J Obes (Lond) 2012 0.94
78 Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms. Neurobiol Aging 2001 0.93
79 Change in cardiovascular risk factors in France, 1985-1997. Eur J Epidemiol 2004 0.92
80 Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 1997 0.91
81 Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett 1994 0.91
82 The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol 2000 0.91
83 Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) 2008 0.91
84 Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart 2009 0.91
85 Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Mol Psychiatry 2004 0.90
86 Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999 0.90
87 Cognitive decline and survival in Alzheimer's disease according to education level. Dement Geriatr Cogn Disord 2007 0.90
88 Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet 1999 0.89
89 Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. Atherosclerosis 2000 0.89
90 Morphology, homogeneity and functionality of human monocytes-derived macrophages. Cell Mol Biol (Noisy-le-grand) 2003 0.89
91 Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 2003 0.89
92 Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 2002 0.88
93 [Epidemiology of sudden coronary death in France (1985-1982)]. Arch Mal Coeur Vaiss 1997 0.88
94 Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart 1997 0.88
95 Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond) 2009 0.88
96 Heart tumors specifically induced in young avian embryos by the v-myc oncogene. Proc Natl Acad Sci U S A 1987 0.88
97 Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int J Obes Relat Metab Disord 1998 0.88
98 An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000 0.87
99 Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel. Neurosci Lett 1996 0.86
100 Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997 0.86
101 Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995 0.86
102 Is hospital care involved in inequalities in coronary heart disease mortality? Results from the French WHO-MONICA Project in men aged 30-64. J Epidemiol Community Health 1998 0.86
103 Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study. Atherosclerosis 2007 0.86
104 Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease. Eur J Neurol 1999 0.86
105 TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study. J Thromb Haemost 2005 0.86
106 Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - The MONICA study 1995-97. Diabetes Metab 2001 0.85
107 Blood lipid concentrations and risk of myocardial infarction. Lancet 2001 0.85
108 Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis 1999 0.85
109 Influence of maternal educational level on the association between the rs3809508 neuromedin B gene polymorphism and the risk of obesity in the HELENA study. Int J Obes (Lond) 2009 0.85
110 Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease. Mol Psychiatry 2003 0.84
111 Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000 0.84
112 Rearrangement of chromosome 21 in Alzheimer's disease. Ann Genet 1986 0.84
113 Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis 2011 0.84
114 Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro. J Vasc Res 1998 0.84
115 Influence of parental histories of cardiovascular risk factors on risk factor clusters in the offspring. Diabetes Metab 2001 0.83
116 Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. Neurology 1998 0.83
117 Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995 0.83
118 Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry 2007 0.83
119 Characterization of a MH2 mutant lacking the v-myc oncogene. Virology 1986 0.83
120 Association between the frequency of fruit and vegetable consumption and cardiovascular disease in male smokers and non-smokers. Eur J Clin Nutr 2010 0.83
121 Linkage exclusion in French families with probable Parkinson' s disease. Mov Disord 2000 0.83
122 Do lifestyle behaviours explain socioeconomic differences in all-cause mortality, and fatal and non-fatal cardiovascular events? Evidence from middle aged men in France and Northern Ireland in the PRIME Study. Prev Med 2012 0.83
123 A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 2000 0.83
124 Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol 1998 0.83
125 Patterns of alcohol consumption in middle-aged men from France and Northern Ireland. The PRIME study. Eur J Clin Nutr 2000 0.83
126 No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. J Neural Transm (Vienna) 2001 0.82
127 Genetic susceptibility factors for Alzheimer's disease. Eur J Pharmacol 2001 0.82
128 No association of the HLA-A2 allele with Alzheimer's disease. Neurosci Lett 2002 0.82
129 Characteristics of male vitamin supplement users aged 50-59 years in France and Northern Ireland: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Int J Vitam Nutr Res 2000 0.82
130 VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 2001 0.82
131 CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections. Int J Stroke 2009 0.81
132 Do cardiovascular risk factors in men depend on their spouses' occupational category? Eur J Epidemiol 2001 0.81
133 [Secondary prevention of coronary disease in France. Result of the EUROASPIRE study: the Lille register of ischemic cardiopathies]. Arch Mal Coeur Vaiss 1998 0.81
134 Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty. Clin Chim Acta 2000 0.81
135 The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 2001 0.81
136 Genetic analysis of synphilin-1 in familial Parkinson's disease. Neurobiol Dis 2001 0.81
137 No pathogenic mutations in the persyn gene in Parkinson's disease. Neurosci Lett 1999 0.81
138 Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. Circulation 2000 0.81
139 Trends and geographical disparities in coronary heart disease in France: are results concordant when different definitions of events are used? Int J Epidemiol 1999 0.80
140 Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes. Am J Med Genet 2001 0.80
141 Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du Myocarde. Atherosclerosis 1995 0.80
142 Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty. Blood Coagul Fibrinolysis 2001 0.80
143 Association study of Notch 4 polymorphisms with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004 0.80
144 Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am J Med Genet 2001 0.79
145 Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population. Arterioscler Thromb Vasc Biol 2000 0.79
146 Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly. Mol Psychiatry 2007 0.79
147 Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab 2009 0.79
148 Association of macronutrient intake patterns with being overweight in a population-based random sample of men in France. Diabetes Metab 2009 0.79
149 [Prevalence of dyslipidaemias in a representative sample of the French population]. Arch Mal Coeur Vaiss 2005 0.79
150 Assessment of Nurr1 nucleotide variations in familial Parkinson's disease. Neurosci Lett 2004 0.79
151 Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. The EVA Study Group. Neurobiol Aging 2000 0.78
152 Cigarette smoking is associated with differences in nutritional habits and related to lipoprotein alterations independently of food and alcohol intake. Eur J Clin Nutr 1996 0.78
153 [Declared knowledge, beliefs and practices for cardiovascular disease prevention in the French population]. Rev Epidemiol Sante Publique 2001 0.78
154 Relevance and limitations of public databases for microarray design: a critical approach to gene predictions. Pharmacogenomics J 2003 0.78
155 ACE gene polymorphism and coronary restenosis. Semin Interv Cardiol 1999 0.78
156 Ambulatory heart failure management in private practice in France. Eur J Heart Fail 2001 0.78
157 Thyroid hormone receptor alpha gene variants increase the risk of developing obesity and show gene-diet interactions. Int J Obes (Lond) 2013 0.78
158 Homocysteine and coronary heart disease risk in the PRIME study. Atherosclerosis 2006 0.78
159 Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease. Acta Neuropathol 1996 0.78
160 Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France. Diabetes Metab 2008 0.78
161 [Therapeutic management of myocardial infarction: trends observed in the MONICA-France project between 1985 and 1991]. Rev Epidemiol Sante Publique 1996 0.78
162 [The OSCAR registry. Registry of acute coronary syndromes]. Ann Cardiol Angeiol (Paris) 2003 0.78
163 No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett 1999 0.77
164 Regional factors interact with educational and income tax levels to influence food intake in France. Eur J Clin Nutr 2011 0.77
165 Why mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern Europe. BMJ 2000 0.77
166 A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form. Neuroreport 1999 0.77
167 Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels. Metabolism 1997 0.77
168 Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. J Hum Hypertens 2002 0.77
169 The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study). Atherosclerosis 2000 0.77
170 ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol 1996 0.76
171 Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics 1999 0.76
172 Proteomic analysis in cardiovascular diseases. Clin Exp Pharmacol Physiol 2008 0.76
173 The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis Assoc Disord 1998 0.76
174 Depression and mortality: artifact of measurement and analysis? J Affect Disord 2013 0.76
175 Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element. Mol Cell Probes 2003 0.76
176 Contribution of lifetime smoking habit in France and Northern Ireland to country and socioeconomic differentials in mortality and cardiovascular incidence: the PRIME Study. J Epidemiol Community Health 2011 0.76
177 Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study. Atherosclerosis 2001 0.76
178 [Coronary mortality in France according to data sources]. Rev Epidemiol Sante Publique 2006 0.75
179 Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans. Int J Obes Relat Metab Disord 2001 0.75
180 Alcohol consumption patterns and body weight. Ann Nutr Metab 2013 0.75
181 Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study. J Epidemiol Community Health 1999 0.75
182 Which measure of adiposity for primary care? Int J Clin Pract 2009 0.75
183 Myocardial infarction rates are higher on weekends than on weekdays in middle aged French men. Heart 2001 0.75
184 Apolipoprotein E in Creutzfeldt-Jakob disease. French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 1995 0.75
185 Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis. Eur Heart J 1998 0.75
186 Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002 0.75
187 Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis. J Thromb Haemost 2012 0.75
188 [Biological banks of the prospective cohort PRIME Study]. Rev Epidemiol Sante Publique 2003 0.75
189 Anticardiolipin antibodies and physical disability in the elderly. Ann Intern Med 1997 0.75
190 [Observations on the management of cardiac failure in ambulatory patients. Results of a survey of cardiologists]. Arch Mal Coeur Vaiss 2001 0.75
191 [Treatments of ischemic cardiopathies (IC) and modalities of prescription of aspirin in the three French MONICA centers in 1990]. Ann Cardiol Angeiol (Paris) 1995 0.75
192 Nutritional intakes of 1072 French free-living men with and without diagnosed cardiovascular risk factors. Eur J Clin Nutr 2004 0.75
193 [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study]. Rev Epidemiol Sante Publique 2001 0.75
194 No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population. J Neural Transm (Vienna) 2002 0.75
195 Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial. J Hypertens Suppl 2003 0.75
196 Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 1993 0.75
197 [Coronary disease in France: data from the MONICA registers (1985-1991)]. Rev Epidemiol Sante Publique 1996 0.75
198 Paraoxonase (Gln192-Arg) polymorphism in French type 2 diabetics. Atherosclerosis 1999 0.75
199 The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans. Arterioscler Thromb Vasc Biol 1997 0.75
200 Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME study. J Hum Hypertens 2000 0.75
201 Type A behaviour and consumption of an atherogenic diet: no association in the PRIME study. Appetite 2007 0.75
202 [Detection of the Arg 3500-->Gln mutation of B apolipoprotein. Value in clinical practice]. Presse Med 1995 0.75
203 [Biological status of adolescent girls using estrogen-progestins]. Contracept Fertil Sex 1995 0.75
204 The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro. J Am Coll Cardiol 1999 0.75
205 Fruit and vegetable intake and smoking cessation. Eur J Clin Nutr 2012 0.75
206 [Treating heart failure with carvedilol in private practice (initiating treatment and follow-up at one year. The KEOPS study]. Arch Mal Coeur Vaiss 2007 0.75
207 [Representative observations of therapies in arterial hypertension]. Arch Mal Coeur Vaiss 2001 0.75
208 Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresis. Clin Chim Acta 1990 0.75
209 Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study. Thromb Res 2001 0.75
210 Very low density lipoprotein receptor in Alzheimer disease. Microsc Res Tech 2000 0.75
211 Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction: the PRIME study. Int J Cardiol 2000 0.75
212 Transdermal estrogen replacement therapy and plasma lipids in 693 French women. Maturitas 1998 0.75